Recap: Ironwood Pharmaceuticals Q1 Earnings


Ironwood Pharmaceuticals IRWD reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.


Ironwood Pharmaceuticals beat estimated earnings by 4.17%, reporting an EPS of $0.25 versus an estimate of $0.24.

Revenue was up $6.53 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.41% increase in the share price the next day.

Here's a look at Ironwood Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.27 0.26 0.30 0.25
EPS Actual 0.27 0.28 0.21 0.21
Revenue Estimate 110.84M 109.11M 103.51M 94.35M
Revenue Actual 107.20M 108.64M 97.23M 97.53M

To track all earnings releases for Ironwood Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!